flooidCX Corp.

2022 Q1 Form 10-Q Financial Statement

#000147793222000331 Filed on January 18, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $590.00 $7.060K $690.00
YoY Change -52.8% 42.91% -83.21%
Cash & Equivalents $587.00 $7.059K $694.00
Short-Term Investments
Other Short-Term Assets $7.730K $10.01K $13.62K
YoY Change -0.13% -31.77% -22.57%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.320K $17.07K $14.31K
YoY Change -49.18% -26.93% -34.06%
LONG-TERM ASSETS
Property, Plant & Equipment $12.20K $12.99K $13.32K
YoY Change -20.87% -37.53% -60.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.20K $12.99K $13.32K
YoY Change -20.87% -37.53% -60.67%
TOTAL ASSETS
Total Short-Term Assets $8.320K $17.07K $14.31K
Total Long-Term Assets $12.20K $12.99K $13.32K
Total Assets $20.52K $30.06K $27.63K
YoY Change -35.45% -31.93% -50.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $360.9K $283.8K $294.0K
YoY Change 6.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.436M $3.332M $3.227M
YoY Change 9.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.037M $4.738M $4.681M
YoY Change 15.23% 17.03% 18.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.037M $4.738M $4.681M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.037M $4.738M $4.681M
YoY Change 15.23% 16.14% 18.03%
SHAREHOLDERS EQUITY
Retained Earnings -$57.00M -$56.71M
YoY Change 1.49%
Common Stock $2.021K $2.021K
YoY Change 2.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.017M -$4.708M -$4.654M
YoY Change
Total Liabilities & Shareholders Equity $20.52K $30.06K $27.63K
YoY Change -35.45% -31.93% -50.28%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Gain Loss On Sale Of Debt Investments
GainLossOnSaleOfDebtInvestments
0 USD
us-gaap Gain Loss On Sale Of Debt Investments
GainLossOnSaleOfDebtInvestments
-21516 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4339988 USD
CY2021Q2 flcx Shares Returned And Cancelled Amount
SharesReturnedAndCancelledAmount
0 USD
CY2021Q2 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
10355 USD
CY2021Q2 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
89887 USD
CY2021Q2 flcx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-198558 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-280378 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2020871 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2020871 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1976218 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4339988 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30055 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
210632 USD
us-gaap Gain Loss On Sale Of Debt Investments
GainLossOnSaleOfDebtInvestments
0 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Debt Investments
GainLossOnSaleOfDebtInvestments
-21516 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10009 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7741 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17068 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
16372 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12987 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15412 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7059 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1251 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7380 USD
CY2021Q4 us-gaap Assets
Assets
30055 USD
CY2021Q1 us-gaap Assets
Assets
31784 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
283814 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
282760 USD
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3332249 USD
CY2021Q1 us-gaap Loans Payable Current
LoansPayableCurrent
3143792 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1121527 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
945220 USD
CY2021Q4 us-gaap Liabilities
Liabilities
4737590 USD
CY2021Q1 us-gaap Liabilities
Liabilities
4371772 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2021 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1976 USD
CY2021Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
9772 USD
CY2021Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
19497 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51874206 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51728412 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
115162 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74510 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56709696 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56165383 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4707535 USD
us-gaap Operating Expenses
OperatingExpenses
590632 USD
us-gaap Operating Expenses
OperatingExpenses
1114726 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
169715 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31784 USD
CY2021Q4 us-gaap Revenues
Revenues
41280 USD
CY2020Q4 us-gaap Revenues
Revenues
12409 USD
us-gaap Revenues
Revenues
53953 USD
us-gaap Revenues
Revenues
66909 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83482 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24954 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244513 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
335322 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
86233 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
185678 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
346119 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
779404 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-128435 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-198223 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-536679 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1047817 USD
CY2021Q4 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3854 USD
CY2020Q4 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
29484 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7634 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
58662 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-132289 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-249223 USD
us-gaap Net Income Loss
NetIncomeLoss
-544313 USD
us-gaap Net Income Loss
NetIncomeLoss
-1127995 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58144 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18956 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
40652 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-130271 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-74145 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-268179 USD
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-503661 USD
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-1258266 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1961587 shares
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1961997 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1958740 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1938194 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7380 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4718682 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13125 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2268 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3647 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6580 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
49024 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
84201 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
137863 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-314660 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-343067 USD
us-gaap Net Income Loss
NetIncomeLoss
-1127995 USD
us-gaap Depreciation
Depreciation
3172 USD
us-gaap Depreciation
Depreciation
4077 USD
flcx Financing Costs
FinancingCosts
7634 USD
flcx Financing Costs
FinancingCosts
54678 USD
us-gaap Share Based Compensation
ShareBasedCompensation
500998 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
816 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1420 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-816 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1420 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
202607 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
370339 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
28090 USD
flcx Proceeds From Related Party Loans
ProceedsFromRelatedPartyLoans
102967 USD
flcx Proceeds From Related Party Loans
ProceedsFromRelatedPartyLoans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
305574 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
342249 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
15710 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-24844 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5808 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27082 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1251 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32025 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7059 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4943 USD
flcx Shares Issued To Settle Financing Cost Payable
SharesIssuedToSettleFinancingCostPayable
0 USD
flcx Shares Issued To Settle Financing Cost Payable
SharesIssuedToSettleFinancingCostPayable
25500 USD
CY2021Q3 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
9908 USD
CY2021Q4 flcx Working Capital Deficit
WorkingCapitalDeficit
-4720522 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56709696 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-314660 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80437 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80314 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67450 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64902 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12987 USD
CY2021Q3 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
5718 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15412 USD
CY2020Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
17648 shares
CY2020Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25500 USD
CY2020Q4 us-gaap Repayments Of Longterm Loans From Vendors
RepaymentsOfLongtermLoansFromVendors
3984 USD
CY2020Q4 flcx Extension Of The Maturity Date Of The Loan
ExtensionOfTheMaturityDateOfTheLoan
2020-11-25
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
283368 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.00
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
52941 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336309 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
0
flcx Range Of Exercise Prices
RangeOfExercisePrices
17.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336309 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
17.00
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
336309 shares
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
17.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0027 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.84 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.84 pure
flcx Fair Value Of Recognized Expense
FairValueOfRecognizedExpense
106103 USD
flcx Fair Value Of Recognized Expense
FairValueOfRecognizedExpense
477384 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.48
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
17.00
CY2020Q4 flcx Fair Value Of Shares To Be Issued For Services Amount
FairValueOfSharesToBeIssuedForServicesAmount
0 USD
CY2020Q4 flcx Fair Value Of Shares Issued As Financing Cost Amount
FairValueOfSharesIssuedAsFinancingCostAmount
25500 USD
CY2020Q4 flcx Fair Value Of Shares Issued To Settle Debt Amount
FairValueOfSharesIssuedToSettleDebtAmount
25500 USD
CY2020Q4 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
83077 USD
CY2020Q4 flcx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-18956 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-249223 USD
CY2021Q3 flcx Foreign Exchange Translation Gain
ForeignExchangeTranslationGain
181066 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-131646 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-4653636 USD
CY2021Q4 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
9772 USD
CY2021Q4 flcx Shares Issued For Services Amount
SharesIssuedForServicesAmount
0 USD
CY2021Q4 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
10474 USD
CY2021Q4 flcx Foreign Exchange Translation Gain
ForeignExchangeTranslationGain
58144 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-132289 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4707535 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-3357941 USD
CY2020Q2 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
9067 USD
CY2020Q2 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
276192 USD
CY2020Q2 flcx Foreign Exchange Translation Gain
ForeignExchangeTranslationGain
85043 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-492660 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-3480299 USD
CY2020Q3 flcx Fair Value Of Shares Issued For Services Amount
FairValueOfSharesIssuedForServicesAmount
0 USD
CY2020Q3 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
9584 USD
CY2020Q3 flcx Fair Value Of Shares Issued As Financing Cost
FairValueOfSharesIssuedAsFinancingCost
24500 USD
CY2020Q3 flcx Fair Value Of Stock Options Granted
FairValueOfStockOptionsGranted
118115 USD
CY2020Q3 flcx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-196358 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-386112 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-3910570 USD
CY2020Q4 flcx Fair Value Of Shares Issued For Services
FairValueOfSharesIssuedForServices
9641 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4035031 USD
us-gaap Net Income Loss
NetIncomeLoss
-544313 USD
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
0 USD
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
21516 USD
us-gaap Share Based Compensation
ShareBasedCompensation
136114 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1.</strong></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Nature of Operations and Continuance of Business</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">flooidCX Corp. (formerly Gripevine, Inc. and Baixo Relocation Services, Inc.) (the “Company”) was incorporated in the state of Nevada on January 7, 2014. The Company is in the business of developing and building an online resolution platform.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, have adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant, but management continues to monitor the situation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, creditors, and related parties, and the ability of the Company to obtain necessary equity financing to continue operations, and ultimately the attainment of profitable operations. As at November 30, 2021, the Company has a working capital deficit of $4,720,522 and an accumulated deficit of $56,709,696 since inception. As at November 30, 2021, the Company is in default of certain loans payable (refer to Note 4). Furthermore, during the nine months ended November 30, 2021, the Company used $314,660 in operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p></td></tr></tbody></table>
flcx Loss On Settlement Of Debt
LossOnSettlementOfDebt
21516 USD
flcx Cancelled
Cancelled
17.00

Files In Submission

Name View Source Status
0001477932-22-000331-index-headers.html Edgar Link pending
0001477932-22-000331-index.html Edgar Link pending
0001477932-22-000331.txt Edgar Link pending
0001477932-22-000331-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flcx-20211130.xsd Edgar Link pending
flcx-20211130_cal.xml Edgar Link unprocessable
flcx-20211130_def.xml Edgar Link unprocessable
flcx-20211130_lab.xml Edgar Link unprocessable
flcx-20211130_pre.xml Edgar Link unprocessable
flcx_10q.htm Edgar Link pending
flcx_10q_htm.xml Edgar Link completed
flcx_ex311.htm Edgar Link pending
flcx_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending